Suspension of trading
Sektor SpringWorks Therapeutics, Inc.
Aktien
A2PRLN
US85205L1070
SWTX
Pharmazeutika
|
Verzögert
Nasdaq
22:00:00 30.06.2025
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 46.99 USD | +0.02% |
|
-.--% | - |
| 01.12. | Tyra Bioscience ernennt Bhavesh Ashar zum Chief Operating Officer | MT |
| 10.11. | Edgewise Therapeutics ernennt Michael Nofi zum Finanzvorstand | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.02% | -.--% | -.--% | -.--% | -.--% | -.--% | +97.52% | -31.60% | - | 3.54 Mrd. | |
| +2.08% | +29.11% | +32.89% | +195.64% | +574.40% | +712.09% | +102.69% | -53.76% | - | 79.4 Mrd. | |
| -1.00% | +0.41% | -3.28% | +24.51% | +2.09% | +39.75% | -5.33% | +23.34% | +95.00% | 78.69 Mrd. | |
| -1.21% | +0.77% | +2.62% | +54.04% | +2.49% | -8.90% | -30.77% | -43.29% | +66.78% | 59.52 Mrd. | |
| +1.18% | +3.03% | -2.99% | -17.06% | -10.14% | +8.89% | +167.27% | +127.36% | +205.15% | 46.58 Mrd. | |
| -1.80% | -2.29% | -14.57% | +1.71% | -19.41% | -11.16% | +30.65% | -3.64% | - | 46.53 Mrd. | |
| +0.55% | +5.61% | +2.95% | +5.36% | +29.33% | +65.68% | -11.80% | -21.98% | -26.54% | 33.63 Mrd. | |
| -0.44% | -1.13% | -3.30% | +8.91% | +25.43% | +49.81% | +108.99% | +79.55% | +39.58% | 25.11 Mrd. | |
| -0.10% | +3.21% | -9.20% | +32.67% | +30.75% | +6.92% | +160.99% | +37.42% | - | 22.13 Mrd. | |
| +0.05% | -2.42% | -6.03% | -6.44% | +31.07% | +60.01% | +97.55% | +82.66% | +317.42% | 15.31 Mrd. | |
| +0.20% | -1.38% | -19.74% | -5.39% | -27.70% | -27.29% | +413.43% | +385.68% | +5’552.17% | 12.82 Mrd. | |
| -1.07% | -1.56% | -17.39% | -6.65% | -14.28% | +31.01% | +146.69% | +35.00% | - | 12.82 Mrd. | |
| -1.78% | -5.76% | -8.15% | +2.14% | +1.40% | +11.90% | -31.57% | -23.33% | -37.14% | 11.66 Mrd. | |
| -0.65% | +9.49% | +21.84% | +83.12% | +476.39% | +579.41% | +820.13% | +63.08% | - | 11.46 Mrd. | |
| +0.25% | +2.72% | -3.87% | -7.10% | +40.27% | +106.07% | +199.80% | +514.35% | - | 10.24 Mrd. | |
| -0.48% | -6.11% | -5.82% | -19.27% | +6.82% | +67.09% | +169.24% | +484.10% | +2’477.15% | 10.22 Mrd. | |
| +2.06% | +0.54% | -4.39% | +5.13% | -10.34% | -20.32% | -21.71% | -56.33% | -50.07% | 6.53 Mrd. | |
| -1.50% | +6.57% | +3.00% | +36.58% | +7.89% | -5.93% | +64.66% | -5.62% | - | 6.51 Mrd. | |
| -0.35% | -2.80% | -4.58% | +26.82% | +82.01% | +105.76% | +350.12% | +546.13% | - | 5.86 Mrd. | |
| -5.20% | -3.14% | -10.05% | -5.43% | -4.56% | +1.58% | +163.58% | +189.19% | - | 5.23 Mrd. | |
| Durchschnitt | -0.46% | +1.74% | -2.50% | +20.47% | +61.20% | +88.62% | +149.61% | +116.42% | +863.95% | 25.19 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.15% | +5.17% | +1.79% | +43.56% | +105.57% | +144.15% | +91.38% | +47.32% | +405.63% |
- Börse
- Aktien
- A2PRLN Aktie
- Sektor SpringWorks Therapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
